Get the Stockscreener App
0.931
12.48%
0.1033
After Hours:
.98
0.049
+5.26%
Oncology Institute Inc stock is traded at $0.931, with a volume of 492.96K.
It is up +12.48% in the last 24 hours and down -3.02% over the past month.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
See More
Previous Close:
$0.8277
Open:
$0.835
24h Volume:
492.96K
Relative Volume:
0.65
Market Cap:
$70.35M
Revenue:
$361.07M
Net Income/Loss:
$-71.54M
P/E Ratio:
-1.1785
EPS:
-0.79
Net Cash Flow:
$-47.97M
1W Performance:
+43.92%
1M Performance:
-3.02%
6M Performance:
+215.91%
1Y Performance:
-37.09%
1-Day Range:
$0.835
$0.99
1-Week Range:
$0.63
$0.99
52-Week Range:
$0.1253
$1.89
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
0.931 | 70.35M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
334.18 | 82.28B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.78 | 14.54B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
149.83 | 13.14B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
127.75 | 12.48B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
178.08 | 11.58B | 15.42B | 1.03B | 956.84M | 15.02 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
Oncology Institute Inc Stock (TOI) Latest News
Ginsenoside Supplement Redsenol-1 Plus Included in National Cancer Institute's Drug Dictionary - 24-7 Press Release
The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call - GlobeNewswire
TOIThe Oncology Institute Inc Latest Stock News & Market Updates - StockTitan
The Oncology Institute, Inc. Scheduled to Release Q4 and Full Year 2024 Financial Results on March 25, 2025 - Nasdaq
Market Cool On The Oncology Institute, Inc.'s (NASDAQ:TOI) Revenues Pushing Shares 28% Lower - Simply Wall St
When Will The Oncology Institute Report Q4 2024 Earnings? Key Date for TOI Investors - StockTitan
The Oncology Institute, Inc. (NASDAQ:TOI) Sees Significant Increase in Short Interest - MarketBeat
The Oncology Institute, Inc. (NASDAQ:TOI) Short Interest Up 188.3% in February - Defense World
Oncology Institute Amends Facility Agreement with Deerfield - TipRanks
The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown - The Manila Times
TOI Slashes Debt While Expanding Patient Base: What's Behind This Strategic Financial Move? - StockTitan
NCCN Announces New Gastrointestinal Cancer Research Grants in Collaboration with Taiho Oncology, Inc. - BioSpace
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology - ACCESS Newswire
Oncology Institute (NASDAQ:TOI) Trading Down 6.9%Here's What Happened - MarketBeat
Oncology Institute (NASDAQ:TOI) Stock Price Down 6.9% – Time to Sell? - Armenian Reporter
A groundbreaking project at the Oncology Institute in Shaare Zedek Medical Center - The Jerusalem Post
In the Green: Oncology Institute Inc (TOI) Closes at 0.82, Up/Down -7.68 from Previous Day - The Dwinnex
Oncology Institute Inc [TOI] Investment Appeal on the Rise - Knox Daily
Singapore Cancer Center opens in Cebu - SunStar Philippines
Market Insights: Oncology Institute Inc (TOI)’s Notable Drop of -3.75, Closing at 0.85 - The Dwinnex
Oncology Institute's Market Cap Up US$7.0m Following Year Of Insider Stock Buying - Yahoo Finance
Oncology Institute Inc (TOI) Stock: A Year of Market Fluctuations - The InvestChronicle
Oncology Institute Inc [TOI] Stock bought by Insider Hively Brad for $42500.0 - Knox Daily
The Oncology Institute Inc (TOI) had a good session last reading, didn’t it? - US Post News
Why The Oncology Institute (TOI) Is Skyrocketing So Far In 2025 - Insider Monkey
The Oncology Institute, Inc. (NASDAQ:TOI) Sees Large Growth in Short Interest - MarketBeat
Cancer Care - Cone Health
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into The Oncology Institute, Inc. - ACCESS Newswire
The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 195% But Many Are Still Ignoring The Company - Simply Wall St
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection - Business Wire
The Oncology Institute Inc WT (TOIIW-Q) QuotePress Release - The Globe and Mail
HighTower Advisors LLC Has $27,000 Stock Position in The Oncology Institute, Inc. (NASDAQ:TOI) - Defense World
Oncology Institute faces potential Nasdaq delisting - Investing.com
Florida Blue enhances cancer care for thousands of members - The Manila Times
Florida Blue Launches Breakthrough Cancer Care Program with The Oncology Institute Partnership - StockTitan
After Dana-Farber Split, Mass General Brigham Cuts New Cancer Path - Oncology News Central
Oncology institute director Brad Hively acquires $50,000 in stock - Investing.com
Oncology institute director Brad Hively acquires $50,000 in stock By Investing.com - Investing.com UK
Tomorrow’s Promise, Today’s Roswell Park: Leaders Tackling the Biggest Priorities in Cancer Care and Treatment - Roswell Park Comprehensive Cancer Center
2024 Face of Hope: Carolina BioOncology Institute - Charlotte magazine
Despite Recent Gains, Oncology Institute Insiders Are Still Down US$110k - Simply Wall St
Shuttle Pharma Expands Patient Enrollment for Phase 2 - GlobeNewswire
Grapevine Saves The Oncology Institute Millions On Healthcare Supplies - Markets Insider
Oncology Institute Inc (NASDAQ: TOI): Blank Check For Growth? - Stocks Register
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx's Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial - The Manila Times
RenovoRx Expands Phase III Pancreatic Cancer Trial with Major Cancer Institute Partnership - StockTitan
Oncology Institute Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.19 loss in 3Q 2023) - Yahoo Finance
The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2024 Earnings Call Transcript - Insider Monkey
USF and TGH partner with robotics company to become the first to bring life-saving surgical technology to Tampa Bay - University of South Florida
Earnings call: The Oncology Institute reports strong growth in Q3 2024 - Investing.com
Oncology Institute Reports Strong Revenue Growth Amid Challenges - TipRanks
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):